Holen Sie sich die Stockscreener-App
0.539
16.76%
0.088
Schlusskurs vom Vortag:
$0.451
Offen:
$0.45
24-Stunden-Volumen:
1.08M
Relative Volume:
0.09
Marktkapitalisierung:
$9.34M
Einnahmen:
$456.00K
Nettoeinkommen (Verlust:
$-20.64M
KGV:
-0.22
EPS:
-2.45
Netto-Cashflow:
$-5.85M
1W Leistung:
+27.51%
1M Leistung:
+26.25%
6M Leistung:
-50.79%
1J Leistung:
-68.84%
1-Tages-Spanne:
$0.4308
$0.546
1-Wochen-Bereich:
$0.401
$0.53
52-Wochen-Spanne:
$0.162
$2.75
Mangoceuticals Inc Stock (MGRX) Company Profile
Firmenname
Mangoceuticals Inc
Sektor
Branche
Telefon
(833) 626-4679
Adresse
15110 DALLAS PKWY, SUITE 600, DALLAS
Compare MGRX vs VEEV, BTSG, TEM, HQY, HNGE
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MGRX
Mangoceuticals Inc
|
0.5439 | 7.74M | 456.00K | -20.64M | -5.85M | -2.45 |
VEEV
Veeva Systems Inc
|
158.00 | 26.14B | 3.20B | 908.91M | 1.39B | 5.4168 |
BTSG
Brightspring Health Services Inc
|
60.19 | 11.34B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
46.69 | 8.29B | 1.36B | -302.91M | -219.93M | -1.7182 |
HQY
Healthequity Inc
|
87.83 | 7.39B | 1.31B | 215.20M | 408.32M | 2.4627 |
HNGE
Hinge Health Inc
|
53.27 | 4.28B | 646.34M | -512.40M | 202.76M | -6.6871 |
Mangoceuticals Inc Aktie (MGRX) Neueste Nachrichten
Mangoceuticals Inc. (MGRX) Holds Near $0.44 After Marginal Uptick — Support and Resistance TightenVolume Profile - Newser
MGRX Price Today: Mangoceuticals, Inc. Stock Price, Quote & Chart | MEXC - MEXC
MANGOCEUTICALS, INC. 1Q 2026: Revenue $67.9K, EPS $(0.22) — 10-Q Summary - TradingView
Mangoceuticals (NASDAQ: MGRX) Q1 2026 shows small sales, heavy loss and thin cash - Stock Titan
MGRX: Net loss narrowed but liquidity and Nasdaq compliance risks persist, requiring urgent funding - TradingView
Mangoceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Mangoceuticals Delays Quarterly Filing After Audit Review - TipRanks
[NT 10-Q] MANGOCEUTICALS, INC. SEC Filing - Stock Titan
MGRX Stock Price, Quote & Chart | MANGOCEUTICALS INC (NASDAQ:MGRX) - ChartMill
MGRX (Mangoceuticals) Q3 loss widens, but stock rallies 7% on positive outlook.Rating Upgrade - Newser
Mangoceuticals stock doubles after Texas lawsuit - MSN
Is Mangoceuticals (MGRX) stock near support |Real-time Trade Ideas - Cổng thông tin điện tử tỉnh Lào Cai
Mangoceuticals (MGRX) Stock: Market Structure (Buying Pressure) 2026-04-20Collaborative Trading Signals - Newser
Mangoceuticals (MGRX) Stock: Should You Take Exposure (Smart Money Exits) 2026-04-18Top Analyst Buy Signals - Xã Thanh Hà
Mangoceuticals Inc. (MGRX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Aug Final Week: Can Mangoceuticals Inc expand its profit marginsBull Run & Free Technical Confirmation Trade Alerts - baoquankhu1.vn
Support Test: Will Mangoceuticals Inc outperform tech stocksMarket Trend Report & Technical Pattern Based Signals - baoquankhu1.vn
Ideas Watch: Can Mangoceuticals Inc expand into new markets2026 Selloffs & Reliable Volume Spike Alerts - baoquankhu1.vn
Is Mangoceuticals (MGRX) Stock Breaking Out | Price at $0.34, Up 0.30%Bearish Sentiment - Newser
Aug Chart Watch: Does Mangoceuticals Inc have a sustainable dividendQuarterly Trade Review & AI Enhanced Trading Alerts - baoquankhu1.vn
Head to Head Analysis: Lyell Immunopharma (NASDAQ:LYEL) & Mangoceuticals (NASDAQ:MGRX) - Defense World
Institution Moves: Will Mangoceuticals Inc benefit from seasonality2026 Big Picture & Weekly Consistent Profit Watchlists - baoquankhu1.vn
Mangoceuticals Inc stock falls amid market weakness - Intellectia AI
Securities.io - Securities.io
Mangoceuticals, Inc. (MGRX) stock price, news, quote and history - Yahoo Finance UK
MGRX Stock Analysis: Mangoceuticals Inc down 2.19% to $0.35, wellness stock outlook - Newser
MGRX: 2025 net loss widened to $20.6M on $456K revenue, with ongoing funding and dilution risks - TradingView
Mangoceuticals, Inc. (MGRX) 2025 Annual Report – Financials, Equity, and Consulting Agreements Overview - Minichart
Mangoceuticals 10-K: Revenue $0.456M, EPS loss $(2.17) - TradingView — Track All Markets
Mangoceuticals (NASDAQ: MGRX) details 1-for-15 reverse split and $100M Solana treasury vision - Stock Titan
Mangoceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Mangoceuticals Delays Annual 10-K Yearly Filing - TipRanks
MGRX SEC FilingsMangoceuticals, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Why Faraday Future Intelligent Electric shares are trading higher by around 55%; here are 20 stocks moving premarket - MSN
Penny Stocks To Watch Today – March 23rd - Defense World
Risks Report: How does Mangoceuticals Inc perform in inflationary periods2026 Patterns & Smart Money Movement Tracker - baoquankhu1.vn
MGRX Mangoceuticals (NASDAQ) pre-market +99.81% Mar 24, 2026: watch heavy volume - Meyka
Mag Mile Capital (OTCQB: MMCP) Surges 365% as CRE Financing Pipeline Expands Across Key Sectors - marketscreener.com
Mangoceuticals (MGRX) Stock Rockets 130% Following CEO’s Substantial Share Award - mexc.com
Mangoceuticals (MGRX) Stock Surges 130% After CEO Lands 500K Share Bonus - MEXC Exchange
Mangoceuticals Inc (MGRX) Stock Price, Quote, News & History - Benzinga
Mangoceuticals Stock Doubles After Texas Lawsuit - Benzinga
Why Is Mangoceuticals, Inc. Stock (MGRX) Up Today? - TipRanks
Setup Watch: Is Mangoceuticals Inc a good ESG investmentShare Buyback & Growth Oriented Trading Recommendations - baoquankhu1.vn
Layoff Watch: Can Mangoceuticals Inc ride the EV waveWeekly Investment Recap & Free Technical Confirmation Trade Alerts - baoquankhu1.vn
Mangoceuticals stock skyrockets 50% Friday: What's driving the rally? - MSN
Mangoceuticals (MGRX) CEO gets 2M options, bonus shares and trust note deal - Stock Titan
Finanzdaten der Mangoceuticals Inc-Aktie (MGRX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Mangoceuticals Inc-Aktie (MGRX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| JOHNSTON EUGENE M | CFO |
Dec 09 '25 |
Sale |
1.20 |
5,000 |
5,975 |
123,333 |
| JOHNSTON EUGENE M | CFO |
Dec 05 '25 |
Sale |
1.13 |
10,000 |
11,280 |
128,333 |
0.64%
1.54%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):